INHALATION ANESTHESIA MARKET ANALYSIS

Inhalation Anesthesia MarketSize and Trends

The global inhalation anesthesia market was valued at US$ 1,276.0 Mn in 2022 and is forecast to reach a value of US$ 1,918.2 Mn by 2030 at a CAGR of 5.3% between 2023 and 2030. The global inhalation anesthesia market is experiencing strong growth due to the increasing prevalence of chronic disease and growing geriatric (aging) population around the world. Moreover, outbreak of COVID-19 (pandemic) and increase in demand for inhalation anesthesia is expected to propel the market growth.

Global Inhalation Anesthesia Market Trends:

Increase in demand for Sevoflurane is a recent trend

Sevoflurane is the most widely used inhalation anesthetic, owing to its therapeutic advantages and low cost. It is useful in children and adults for induction and maintenance of anesthesia in inpatient surgery and outpatient surgery, and is given before surgery to make induction of general anesthesia substantially easier. It is administered without the use of intravenous route and is ideal for people with asthma and sensitized air passages. Thus, there is an increase in demand for Sevoflurane, and this trend is expected to continue over the forecast period.

Introduction of novel products is another trend

Players in the market are focusing on developing and launching novel products to meet the increasing demand for inhalation anesthesia worldwide. In January 2019, Sandoz International announced the launch of Desflurane liquid as an inhalation agent for the induction and maintenance of anesthesia, required for inpatient and outpatient surgery in adults and pediatric patients in the U.S. It was the first generic of Suprane in the U.S. This trend is also expected to continue over the forecast period, driving the growth of the global inhalation anesthesia market.